Author:
Gilli Francesca,De La Torre Adrianna L.,Royce Darlene B.,Pachner Andrew R.
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference35 articles.
1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group;Paty;Neurology,1993
2. Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. 1993 [classical article];Paty;Neurology,2001
3. Benefits of high-dose, high-frequency interferon beta-1a in relapsing-remitting multiple sclerosis are sustained to 16 months: final comparative results of the EVIDENCE trial;Panitch;J. Neurol. Sci.,2005
4. Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study;Calabresi;Lancet Neurol.,2014
5. Half-life extended biotherapeutics;Kontermann;Expert. Opin. Biol. Ther.,2016
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献